The independent source for health policy research, polling, and news.
with
41 - 60 of 3,632 Results
Sweeps of encampments scatter homeless people, as medications are tossed and street medicine providers scramble to reconnect with their patients. KFF Health News senior correspondent Angela Hart discusses the aftermath on the Jan. 28 edition of WAMU’s “Health Hub.”
The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast cancer research lab, work that could save lives has slowed significantly.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The federal government’s Vaccine Injury Compensation Program was supposed to help patients with their medical bills while protecting vaccine supply. But allies of Health and Human Services Secretary Robert F. Kennedy Jr. are routinely transferring cases from that program to launch lawsuits against drugmakers.
Studies increasingly offer insights into the health risks and burdens faced by people who have had covid infections. Meanwhile, the Trump administration has narrowed covid vaccine recommendations and cut research.
Lawmakers appear on the brink of passing a spending bill for the Department of Health and Human Services and a bipartisan health policy bill delayed for over a year. But the outlook is bleaker for the health care outline released by President Trump last week. Sandhya Raman of CQ Roll Call, Sheryl Gay Stolberg of The New York Times, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews oncologist and bioethicist Ezekiel Emanuel to discuss his new book, “Eat Your Ice Cream.”
Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.
KFF Health News' editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a collection of her appearances.
Lifesaving or wasteful? Opinion is divided on the ways local communities are using opioid settlement funds. Survivors of the overdose crisis and families who’ve lost loved ones to it are raising alarms about what some perceive as wasteful spending.
Martha Santana-Chin, a daughter of Mexican immigrants, last year took the helm of L.A. Care, the nation’s largest publicly operated health plan. She warns that looming federal cuts will push up to 650,000 people off L.A. Care’s Medicaid rolls by the end of 2028.
Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found.
“Make America Healthy Again” policies driven by HHS Secretary Robert F. Kennedy Jr. have made major strides in state legislatures, with food additives among the most common targets. The trend is expected to continue this year.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Located in the Lower 9th Ward, this abandoned building has become a community sanctuary and resource.
Meth is a problem most everywhere, but particularly in Indian Country. On the Crow Indian Reservation in Montana, new buildings serve as symbols of a town trying to rebuild after being devastated by addiction.
The experiences of one doctor in Louisiana reveal the tensions around trying to get people to engage in addiction treatment, even if they’re not ready to stop using drugs.
The CDC is recommending fewer childhood vaccines, although the ones it has jettisoned from the recommended schedule have successfully battled serious illness for years. Experts warn that if vaccine uptake falls, millions could be hospitalized — or worse — as a result of preventable diseases.
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
During the covid pandemic, gun marketers told many Americans they needed firearms to defend against criminals and protesters. Then firearm deaths mounted rapidly in racially segregated and low-income neighborhoods, according to federal data.
© 2026 KFF